TickerFacts.

Volitionrx Ltd (VNRX): Total Liabilities

Annual figures by period end, from SEC filings.

$42.49M
As of 2025-12-31
$41.84M
As of 2026-06-30
+25.6%
3-year compound annual growth
+33.9%
5-year compound annual growth
+38.2%
10-year compound annual growth
2011-12-31: $1.16M2012-12-31: $1.38M2013-12-31: $1.39M2014-12-31: $3.06M2015-12-31: $1.67M2016-12-31: $3.56M2017-12-31: $4.67M2018-12-31: $5.35M2019-12-31: $7.09M2020-12-31: $9.86M2021-12-31: $9.77M2022-12-31: $21.42M2023-12-31: $36.66M2024-12-31: $35.51M2025-12-31: $42.49M$42.49M
2011-12-31 Total Liabilities (USD) 2025-12-31
Period endedTotal LiabilitiesChange YoYSource filing
2025-12-31$42.49M+19.7%2026-03-31, Balance as of period end
2024-12-31$35.51M-3.2%2026-03-31, Balance as of period end
2023-12-31$36.66M+71.1%2025-03-31, Balance as of period end
2022-12-31$21.42M+119.3%2024-03-25, Balance as of period end
2021-12-31$9.77M-0.9%2023-03-15, Balance as of period end
2020-12-31$9.86M+39.0%2022-03-30, Balance as of period end
2019-12-31$7.09M+32.6%2021-03-22, Balance as of period end
2018-12-31$5.35M+14.6%2020-02-20, Balance as of period end
2017-12-31$4.67M+31.2%2019-03-13, Balance as of period end
2016-12-31$3.56M+113.3%2018-03-01, Balance as of period end
2015-12-31$1.67M-45.6%2017-03-10, Balance as of period end
2014-12-31$3.06M+120.5%2016-03-11, Balance as of period end
2013-12-31$1.39M+0.5%2015-03-18, Balance as of period end
2012-12-31$1.38M+19.6%2014-03-28, Balance as of period end
2011-12-31$1.16Mn/a2013-04-01, Balance as of period end

Total Liabilities at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal LiabilitiesChange YoY
Volitionrx Ltd (VNRX)2025-12-31$42.49M+19.7%
Celldex Therapeutics, Inc. (CLDX)2025-12-31$55.82M+23.1%
Insight Molecular Diagnostics Inc. (IMDX)2025-12-31$57.22M+20.8%
Biomerica Inc (BMRA)2026-05-31$4.13M+124.4%
Anbio Biotechnology (NNNN)2025-12-31$87.8K-94.9%
Aspira Women's Health Inc. (AWHL)2025-12-31$12.39M+53.8%
Immucell Corp (ICCC)2025-12-31$15.48M-12.0%
Alpha Teknova, Inc. (TKNO)2025-12-31$34.81M-4.3%
Intellia Therapeutics, Inc. (NTLA)2025-12-31$170.73M-46.5%

Compare VNRX, CLDX, IMDX, BMRA side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗